94 related articles for article (PubMed ID: 22729898)
41. Oxidative stress disassembles the p38/NPM/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response.
Guillonneau M; Paris F; Dutoit S; Estephan H; Bénéteau E; Huot J; Corre I
FASEB J; 2016 Aug; 30(8):2899-914. PubMed ID: 27142525
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.
Theendakara V; Bredesen DE; Rao RV
Mol Cell Neurosci; 2017 Sep; 83():83-91. PubMed ID: 28720530
[TBL] [Abstract][Full Text] [Related]
43. ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease.
Zhou Y; Liu X; Ma S; Zhang N; Yang D; Wang L; Ye S; Zhang Q; Ruan J; Ma J; Wang S; Jiang N; Zhao Z; Zhao S; Zheng C; Fan X; Gong Y; Abdoul Razak MY; Hu W; Pan J; Wang X; Fan J; Li J; Liu R; Shentu Y
FASEB J; 2022 Mar; 36(3):e22209. PubMed ID: 35195302
[TBL] [Abstract][Full Text] [Related]
44. PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins.
Magnaudeix A; Wilson CM; Page G; Bauvy C; Codogno P; Lévêque P; Labrousse F; Corre-Delage M; Yardin C; Terro F
Neurobiol Aging; 2013 Mar; 34(3):770-90. PubMed ID: 22892312
[TBL] [Abstract][Full Text] [Related]
45. Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models.
Wei H; Zhang HL; Wang XC; Xie JZ; An DD; Wan L; Wang JZ; Zeng Y; Shu XJ; Westermarck J; Lu YM; Ohlmeyer M; Liu R
Neurotherapeutics; 2020 Jul; 17(3):1087-1103. PubMed ID: 32096091
[TBL] [Abstract][Full Text] [Related]
46. p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
Muraleva NA; Kolosova NG; Stefanova NA
Exp Gerontol; 2019 May; 119():45-52. PubMed ID: 30664924
[TBL] [Abstract][Full Text] [Related]
47. PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.
Nicholls RE; Sontag JM; Zhang H; Staniszewski A; Yan S; Kim CY; Yim M; Woodruff CM; Arning E; Wasek B; Yin D; Bottiglieri T; Sontag E; Kandel ER; Arancio O
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3347-52. PubMed ID: 26951658
[TBL] [Abstract][Full Text] [Related]
48. Age-related alterations in protein phosphatase 2A methylation levels in brains of cynomolgus monkeys: a pilot study.
Ando S; Sakurai M; Shibutani S; Kimura N; Shimozawa N; Yasutomi Y; Yabe R; Ohama T; Sato K
J Biochem; 2023 May; 173(6):435-445. PubMed ID: 36702627
[TBL] [Abstract][Full Text] [Related]
49. Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability.
Frasca D; Romero M; Landin AM; Diaz A; Riley RL; Blomberg BB
Mech Ageing Dev; 2010 May; 131(5):306-14. PubMed ID: 20219523
[TBL] [Abstract][Full Text] [Related]
50. Protein phosphatase 2A plays an important role in migration of bone marrow stroma cells.
Chen W; Wang S; Xia J; Huang Z; Tu X; Shen Z
Mol Cell Biochem; 2016 Jan; 412(1-2):173-80. PubMed ID: 26708215
[TBL] [Abstract][Full Text] [Related]
51. Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.
Yu G; Yan T; Feng Y; Liu X; Xia Y; Luo H; Wang JZ; Wang X
Neurobiol Aging; 2013 Jul; 34(7):1748-58. PubMed ID: 23374587
[TBL] [Abstract][Full Text] [Related]
52. N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease.
Ando K; Uemura K; Kuzuya A; Maesako M; Asada-Utsugi M; Kubota M; Aoyagi N; Yoshioka K; Okawa K; Inoue H; Kawamata J; Shimohama S; Arai T; Takahashi R; Kinoshita A
J Biol Chem; 2011 Mar; 286(9):7619-28. PubMed ID: 21177868
[TBL] [Abstract][Full Text] [Related]
53. PP2A and Alzheimer disease.
Torrent L; Ferrer I
Curr Alzheimer Res; 2012 Feb; 9(2):248-56. PubMed ID: 22299660
[TBL] [Abstract][Full Text] [Related]
54. Sulforaphane Upregulates Cultured Mouse Astrocytic Aquaporin-4 Expression through p38 MAPK Pathway.
Yang C; Qin S; Zhang J; Wang Y; Li H; Lü T
J Healthc Eng; 2022; 2022():1144124. PubMed ID: 35991296
[TBL] [Abstract][Full Text] [Related]
55. Control of cell migration by the novel protein phosphatase-2A interacting protein inka2.
Akiyama H; Iwasaki Y; Yamada S; Kamiguchi H; Sakakibara SI
Cell Tissue Res; 2020 Jun; 380(3):527-537. PubMed ID: 31975032
[TBL] [Abstract][Full Text] [Related]
56. Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation.
Yabe R; Miura A; Usui T; Mudrak I; Ogris E; Ohama T; Sato K
PLoS One; 2015; 10(12):e0145226. PubMed ID: 26678046
[TBL] [Abstract][Full Text] [Related]
57. Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease.
Wei H; Zhang HL; Xie JZ; Meng DL; Wang XC; Ke D; Zeng J; Liu R
Curr Med Sci; 2020 Feb; 40(1):1-8. PubMed ID: 32166659
[TBL] [Abstract][Full Text] [Related]
58. Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2.
Zhu LQ; Zheng HY; Peng CX; Liu D; Li HL; Wang Q; Wang JZ
J Neurosci; 2010 Mar; 30(10):3839-48. PubMed ID: 20220019
[TBL] [Abstract][Full Text] [Related]
59. Implication of novel bis-imidazopyridines for management of Alzheimer's disease and establishment of its role on protein phosphatase 2A activity in brain.
Parekh KD; Dash RP; Pandya AN; Vasu KK; Nivsarkar M
J Pharm Pharmacol; 2013 Dec; 65(12):1785-95. PubMed ID: 24117507
[TBL] [Abstract][Full Text] [Related]
60. PP2A Level in Colorectal Cancer Cells Predicts the Response of p38 Targeted Therapy.
Shang C; Huang S
EBioMedicine; 2015 Dec; 2(12):1848-9. PubMed ID: 26844254
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
